OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients ; volume:21 ; number:1 ; day:29 ; month:10 ; year:2020 ; pages:1-6 ; date:12.2020
The journal of headache and pain ; 21, Heft 1 (29.10.2020), 1-6, 12.2020
- Creator
-
Wong, Ho-Tin
Khalil, Modar
Ahmed, Fayyaz
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-020-01196-1
- URN
-
urn:nbn:de:101:1-2020121312302842397441
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wong, Ho-Tin
- Khalil, Modar
- Ahmed, Fayyaz
- SpringerLink (Online service)
Other Objects (12)
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
A prospective real-world analysis of erenumab in refractory chronic migraine
Phenotypic features of chronic migraine
Chronic migraine prevention with topiramate
Cognitive performance in chronic migraine
Good news for chronic migraine
Predictors of chronic migraine remission
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
A prospective real-world analysis of erenumab in refractory chronic migraine
Phenotypic features of chronic migraine
Chronic migraine prevention with topiramate
Cognitive performance in chronic migraine
Good news for chronic migraine
Predictors of chronic migraine remission
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
A prospective real-world analysis of erenumab in refractory chronic migraine
Phenotypic features of chronic migraine
Chronic migraine prevention with topiramate
Cognitive performance in chronic migraine
Good news for chronic migraine
Predictors of chronic migraine remission
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study